This session will discuss key considerations for the diagnosis of patients with Interstitial Lung Disease (ILD) and provide a review on how to incorporate the Envisia Genomic Classifier as part of your ILD workup for a more confident diagnosis and prognosis.

Speakers:

Mary Beth Scholand, MD
Director of the Interstitial Lung Disease Clinic
Associate Professor in Pulmonary Medicine, University of Utah

Fayez Kheir, MD
Director of Interventional Pulmonology Research at Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School

свернуть